Amundi Asset Management US’s FibroGen FGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q1
$15.7M Buy
18,149
+2,284
+14% +$1.98M 0.01% 731
2020
Q4
$14.7M Sell
15,865
-946
-6% -$877K 0.01% 716
2020
Q3
$17.3M Buy
16,811
+1,841
+12% +$1.89M 0.02% 585
2020
Q2
$15.2M Sell
14,970
-1,575
-10% -$1.6M 0.02% 588
2020
Q1
$14.4M Sell
16,545
-432
-3% -$375K 0.03% 481
2019
Q4
$18.2M Buy
16,977
+4
+0% +$4.29K 0.02% 590
2019
Q3
$15.7M Buy
16,973
+261
+2% +$241K 0.02% 576
2019
Q2
$18.9M Buy
16,712
+6,460
+63% +$7.3M 0.02% 594
2019
Q1
$13.9M Sell
10,252
-32
-0.3% -$43.5K 0.02% 631
2018
Q4
$11.9K Buy
10,284
+1,054
+11% +$1.22K 0.01% 606
2018
Q3
$14M Sell
9,230
-67
-0.7% -$102K 0.02% 650
2018
Q2
$14.5M Buy
9,297
+3,080
+50% +$4.82M 0.02% 620
2018
Q1
$7.18M Buy
+6,217
New +$7.18M 0.01% 774